These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37740787)

  • 1. Immunogenic necroptosis in liver diseases: mechanisms and therapeutic potential.
    Ye Z; Zhang N; Lei H; Yao H; Fu J; Zhang N; Xu L; Zhou G; Liu Z; Lv Y
    J Mol Med (Berl); 2023 Nov; 101(11):1355-1363. PubMed ID: 37740787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necroptosis: a regulated inflammatory mode of cell death.
    Dhuriya YK; Sharma D
    J Neuroinflammation; 2018 Jul; 15(1):199. PubMed ID: 29980212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necroptosis signaling in liver diseases: An update.
    Saeed WK; Jun DW; Jang K; Koh DH
    Pharmacol Res; 2019 Oct; 148():104439. PubMed ID: 31476369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
    J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for the detection of necroptosis.
    He S; Huang S; Shen Z
    Cell Mol Life Sci; 2016 Jun; 73(11-12):2177-81. PubMed ID: 27066893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
    Chen J; Kos R; Garssen J; Redegeld F
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necroptosis: a crucial pathogenic mediator of human disease.
    Choi ME; Price DR; Ryter SW; Choi AMK
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis: A Pathogenic Negotiator in Human Diseases.
    Chaouhan HS; Vinod C; Mahapatra N; Yu SH; Wang IK; Chen KB; Yu TM; Li CY
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necroptosis and tumor progression.
    Yan J; Wan P; Choksi S; Liu ZG
    Trends Cancer; 2022 Jan; 8(1):21-27. PubMed ID: 34627742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIPK3 signaling and its role in the pathogenesis of cancers.
    Liu S; Joshi K; Denning MF; Zhang J
    Cell Mol Life Sci; 2021 Dec; 78(23):7199-7217. PubMed ID: 34654937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
    Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
    J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease.
    Zhao W; Liu Y; Xu L; He Y; Cai Z; Yu J; Zhang W; Xing C; Zhuang C; Qu Z
    ACS Chem Neurosci; 2022 Jun; 13(12):1697-1713. PubMed ID: 35607807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting necroptosis in fibrosis.
    Hassanein EHM; Ibrahim IM; Abd El-Maksoud MS; Abd El-Aziz MK; Abd-Alhameed EK; Althagafy HS
    Mol Biol Rep; 2023 Dec; 50(12):10471-10484. PubMed ID: 37910384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glimpse of necroptosis and diseases.
    Yang M; Chen W; He L; Liu D; Zhao L; Wang X
    Biomed Pharmacother; 2022 Dec; 156():113925. PubMed ID: 36411617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.
    Meng Y; Davies KA; Fitzgibbon C; Young SN; Garnish SE; Horne CR; Luo C; Garnier JM; Liang LY; Cowan AD; Samson AL; Lessene G; Sandow JJ; Czabotar PE; Murphy JM
    Nat Commun; 2021 Nov; 12(1):6783. PubMed ID: 34811356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis: an emerging type of cell death in liver diseases.
    Saeed WK; Jun DW
    World J Gastroenterol; 2014 Sep; 20(35):12526-32. PubMed ID: 25253954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice.
    Khodayar MJ; Kalantari H; Khorsandi L; Ahangar N; Samimi A; Alidadi H
    Mol Biol Rep; 2021 May; 48(5):4153-4162. PubMed ID: 34032977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.